CLINICAL_TRIALS
trial_result
· 2017-07-26
Clinical Trial Update: Extension Study of Protocol ENB-006-09 - Study of Asfotase Alfa in Children With Hypophosphatasia (HPP) [Phase 2]
Summary
Extension study update for asfotase alfa in children with hypophosphatasia (Phase 2) completed with results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Hypophosphatasia (HPP) | Phase 2 | Status: COMPLETED | Results posted: 2017-07-26